×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan.
19164213
2009
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
Biomarker
LHGDN
Role of miR-143 targeting KRAS in colorectal tumorigenesis.
19137007
2009
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection.
19124802
2009
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients.
18577988
2008
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
18834226
2008
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
Biomarker
LHGDN
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab.
17998284
2008
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice.
19056857
2008
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.
18202412
2008
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
Biomarker
LHGDN
RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A.
18592002
2008
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer.
18757341
2008
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.
19002263
2008
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
KRAS mutation profile in colorectal carcinoma and novel mutation--internal tandem duplication in KRAS.
18669174
2008
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients.
17704924
2008
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer.
18435933
2008
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutations.
17707462
2007
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
Biomarker
LHGDN
Acquisition of anoikis resistance promotes the emergence of oncogenic K-ras mutations in colorectal cancer cells and stimulates their tumorigenicity in vivo.
17710156
2007
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
K-ras mutation detection in colorectal cancer using the Pyrosequencing technique.
17629419
2007
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression.
16953233
2007
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
Highly conserved sequence of exon 15 BRAF gene and KRAS codon 12 mutation among Greek patients with colorectal cancer.
17393356
2007
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
Oncogenic K-RAS subverts the antiapoptotic role of N-RAS and alters modulation of the N-RAS:gelsolin complex.
17130841
2007
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
Histopathological and genetic differences between polypoid and non-polypoid submucosal colorectal carcinoma.
17465446
2007
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
Involvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma.
17663506
2007
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
AlteredExpression
LHGDN
Activation of extracellular regulated kinases (ERK1/2) but not AKT predicts poor prognosis in colorectal carcinoma and is associated with k-ras mutations.
17149612
2007
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
The differentially mutational spectra of the APC, K-ras, and p53 genes in sporadic colorectal cancers from Taiwanese patients.
18265644
2007
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
Colorectal Neoplasms
0.500
GeneticVariation
LHGDN
Recurrent KRAS codon 146 mutations in human colorectal cancer.
16969076
2006